- Corporate Officers - S
- Smith Mark Douglas
Insider Trading History of Smith Mark Douglas
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Mark Douglas since 2020.
This trader's CIK number is 1756253.
At the time of last reporting, Smith Mark Douglas was the Director of Phreesia, Inc.. (stock ticker symbol PHR).
Also see all insider trading activities at Phreesia, Inc..
Note that in the past
Smith Mark Douglas also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Phreesia, Inc. (PHR) by Smith Mark Douglas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | PHR | 0 | $0 | 7,000 | $203,000 | 7,000 | $32,970 |
| 2024 | PHR | 0 | $0 | 7,000 | $175,000 | 7,000 | $32,970 |
| 2023 | PHR | 0 | $0 | 7,000 | $218,610 | 7,000 | $32,970 |
| 2021 | PHR | 0 | $0 | 6,000 | $318,120 | 6,000 | $28,260 |
| 2020 | PHR | 0 | $0 | 6,000 | $181,824 | 6,000 | $28,260 |
Yearly summary of insider trading at Teladoc Health, Inc. (TDOC) by Smith Mark Douglas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TDOC | 4,000 | $28,312 | 0 | $0 | 0 | $0 |
| 2022 | TDOC | 0 | $0 | 0 | $0 | 819 | $0 |
| 2020 | TDOC | 0 | $0 | 0 | $0 | 3,012 | $0 |
Yearly summary of insider trading at Jazz Pharmaceuticals Plc (JAZZ) by Smith Mark Douglas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | JAZZ | 0 | $0 | 1,658 | $221,189 | 0 | $0 |
| 2022 | JAZZ | 0 | $0 | 1,509 | $230,845 | 0 | $0 |
| 2021 | JAZZ | 0 | $0 | 417 | $50,582 | 0 | $0 |
Insider trading activities at 3 companies by Smith Mark Douglas:
1. Phreesia, Inc. (PHR)
2. Teladoc Health, Inc. (TDOC)
3. Jazz Pharmaceuticals Plc (JAZZ)
Table 1. Insider trading of Phreesia, Inc. (PHR) by Smith Mark Douglas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-07-02 | PHR | Option Ex | 7,000 | 4.71 | 32,970 |
| 2025-07-02 | PHR | Sale | 7,000 | 29.00 | 203,000 |
| 2024-07-18 | PHR | Option Ex | 7,000 | 4.71 | 32,970 |
| 2024-07-18 | PHR | Sale | 7,000 | 25.00 | 175,000 |
| 2023-04-03 | PHR | Option Ex | 7,000 | 4.71 | 32,970 |
| 2023-04-03 | PHR | Sale | 7,000 | 31.23 | 218,610 |
| 2021-01-04 | PHR | Option Ex | 6,000 | 4.71 | 28,260 |
| 2021-01-04 | PHR | Sale | 6,000 | 53.02 | 318,120 |
| 2020-08-10 | PHR | Option Ex | 6,000 | 4.71 | 28,260 |
| 2020-08-10 | PHR | Sale | 6,000 | 30.30 | 181,824 |
Table 2. Insider trading of Teladoc Health, Inc. (TDOC) by Smith Mark Douglas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-15 | TDOC | Buy | 4,000 | 7.08 | 28,312 |
| 2022-05-17 | TDOC | Option Ex | 819 | .00 | 0 |
| 2020-05-28 | TDOC | Option Ex | 3,012 | .00 | 0 |
Table 3. Insider trading of Jazz Pharmaceuticals Plc (JAZZ) by Smith Mark Douglas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-04 | JAZZ | Sale | 417 | 119.27 | 49,735 |
| 2023-08-14 | JAZZ | Sale | 1,241 | 138.16 | 171,454 |
| 2022-12-02 | JAZZ | Sale | 420 | 154.68 | 64,966 |
| 2022-08-08 | JAZZ | Sale | 1,089 | 152.32 | 165,879 |
| 2021-12-02 | JAZZ | Sale | 417 | 121.30 | 50,582 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smith Mark Douglas
(Director of Phreesia, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.